Concepts (193)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Allyl Compounds | 13 | 2024 | 55 | 5.550 |
Why?
|
| Sulfides | 10 | 2024 | 78 | 3.150 |
Why?
|
| Garlic | 5 | 2024 | 31 | 1.970 |
Why?
|
| Precancerous Conditions | 2 | 2024 | 83 | 1.560 |
Why?
|
| Tumor Necrosis Factor-alpha | 5 | 2023 | 384 | 1.540 |
Why?
|
| Chemokine CCL2 | 3 | 2021 | 95 | 1.480 |
Why?
|
| Disulfides | 3 | 2015 | 95 | 1.190 |
Why?
|
| Anticarcinogenic Agents | 6 | 2024 | 77 | 1.160 |
Why?
|
| Benzo(a)pyrene | 5 | 2024 | 128 | 1.110 |
Why?
|
| Reactive Oxygen Species | 5 | 2024 | 532 | 1.010 |
Why?
|
| Prenatal Care | 1 | 2025 | 93 | 0.870 |
Why?
|
| DNA Breaks, Double-Stranded | 3 | 2021 | 40 | 0.830 |
Why?
|
| Breast | 4 | 2021 | 139 | 0.820 |
Why?
|
| Breast Neoplasms | 4 | 2024 | 1723 | 0.800 |
Why?
|
| Epithelial Cells | 3 | 2024 | 434 | 0.760 |
Why?
|
| Breast Feeding | 1 | 2023 | 126 | 0.710 |
Why?
|
| Apoptosis | 10 | 2024 | 1568 | 0.590 |
Why?
|
| Cell Line, Tumor | 9 | 2024 | 2676 | 0.560 |
Why?
|
| Cell Cycle | 8 | 2021 | 346 | 0.490 |
Why?
|
| Carcinogens | 5 | 2012 | 126 | 0.470 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2015 | 11 | 0.460 |
Why?
|
| Plant Extracts | 2 | 2021 | 302 | 0.440 |
Why?
|
| Cell Survival | 9 | 2021 | 945 | 0.430 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2021 | 968 | 0.420 |
Why?
|
| Hepatocytes | 2 | 2011 | 80 | 0.410 |
Why?
|
| MAP Kinase Signaling System | 1 | 2015 | 196 | 0.400 |
Why?
|
| Antioxidants | 3 | 2024 | 443 | 0.390 |
Why?
|
| Florida | 2 | 2025 | 478 | 0.380 |
Why?
|
| Humans | 19 | 2025 | 43102 | 0.360 |
Why?
|
| DNA Damage | 4 | 2024 | 356 | 0.340 |
Why?
|
| Female | 13 | 2025 | 24698 | 0.340 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2012 | 165 | 0.340 |
Why?
|
| Acetylcysteine | 1 | 2010 | 57 | 0.320 |
Why?
|
| Oxidative Stress | 2 | 2025 | 1003 | 0.280 |
Why?
|
| Antineoplastic Agents | 2 | 2014 | 1019 | 0.270 |
Why?
|
| Cell Proliferation | 6 | 2021 | 1455 | 0.270 |
Why?
|
| DNA Repair | 2 | 2024 | 198 | 0.240 |
Why?
|
| Child | 2 | 2025 | 3443 | 0.240 |
Why?
|
| Pregnancy Outcome | 1 | 2025 | 102 | 0.220 |
Why?
|
| Cytochrome P-450 CYP1A1 | 2 | 2024 | 52 | 0.220 |
Why?
|
| Metformin | 1 | 2025 | 75 | 0.210 |
Why?
|
| Astrocytes | 2 | 2019 | 244 | 0.200 |
Why?
|
| Cytokines | 3 | 2021 | 678 | 0.200 |
Why?
|
| Infant Nutritional Physiological Phenomena | 1 | 2023 | 36 | 0.200 |
Why?
|
| Caspases | 1 | 2023 | 148 | 0.190 |
Why?
|
| Imidazoles | 3 | 2015 | 142 | 0.190 |
Why?
|
| Neuroprotective Agents | 1 | 2025 | 269 | 0.190 |
Why?
|
| Dioscorea | 1 | 2021 | 4 | 0.180 |
Why?
|
| DNA Polymerase beta | 1 | 2021 | 14 | 0.180 |
Why?
|
| Bromodeoxyuridine | 1 | 2021 | 25 | 0.180 |
Why?
|
| DNA | 2 | 2024 | 592 | 0.180 |
Why?
|
| Cadmium | 2 | 2011 | 56 | 0.170 |
Why?
|
| Mothers | 1 | 2023 | 215 | 0.170 |
Why?
|
| Infant, Newborn | 1 | 2023 | 972 | 0.160 |
Why?
|
| Pregnancy | 1 | 2025 | 1772 | 0.160 |
Why?
|
| Infant | 1 | 2023 | 1175 | 0.150 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2015 | 187 | 0.150 |
Why?
|
| Cell Line | 6 | 2019 | 1410 | 0.150 |
Why?
|
| Microglia | 2 | 2015 | 208 | 0.150 |
Why?
|
| Retrospective Studies | 1 | 2025 | 2544 | 0.140 |
Why?
|
| Rats | 9 | 2019 | 3735 | 0.140 |
Why?
|
| Gene Expression | 1 | 2021 | 701 | 0.140 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2010 | 166 | 0.140 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2018 | 51 | 0.140 |
Why?
|
| Aldehydes | 1 | 2018 | 70 | 0.140 |
Why?
|
| Cell Movement | 1 | 2021 | 655 | 0.140 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2015 | 458 | 0.130 |
Why?
|
| Doxorubicin | 1 | 2018 | 97 | 0.130 |
Why?
|
| Central Nervous System Stimulants | 1 | 2019 | 180 | 0.130 |
Why?
|
| Methamphetamine | 1 | 2019 | 166 | 0.130 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2018 | 199 | 0.130 |
Why?
|
| Anthracenes | 1 | 2015 | 15 | 0.120 |
Why?
|
| Butadienes | 1 | 2015 | 29 | 0.120 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2015 | 32 | 0.120 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2015 | 21 | 0.110 |
Why?
|
| Flow Cytometry | 3 | 2012 | 411 | 0.110 |
Why?
|
| Benzoquinones | 1 | 2015 | 47 | 0.110 |
Why?
|
| Nitriles | 1 | 2015 | 81 | 0.110 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2015 | 105 | 0.110 |
Why?
|
| Chemoprevention | 2 | 2012 | 41 | 0.110 |
Why?
|
| Comet Assay | 2 | 2012 | 77 | 0.110 |
Why?
|
| Protein Array Analysis | 1 | 2014 | 27 | 0.110 |
Why?
|
| Pyridines | 1 | 2015 | 139 | 0.110 |
Why?
|
| Glutathione Reductase | 2 | 2011 | 19 | 0.110 |
Why?
|
| Young Adult | 1 | 2025 | 5080 | 0.110 |
Why?
|
| Adipokines | 1 | 2014 | 28 | 0.110 |
Why?
|
| Adolescent | 1 | 2025 | 6081 | 0.100 |
Why?
|
| Animals | 12 | 2025 | 16992 | 0.100 |
Why?
|
| Catalase | 2 | 2011 | 110 | 0.100 |
Why?
|
| Glutathione Peroxidase | 2 | 2011 | 112 | 0.100 |
Why?
|
| Tumor Cells, Cultured | 1 | 2014 | 508 | 0.100 |
Why?
|
| Membrane Potential, Mitochondrial | 2 | 2010 | 90 | 0.100 |
Why?
|
| Phosphorylation | 1 | 2015 | 986 | 0.090 |
Why?
|
| Succimer | 1 | 2011 | 4 | 0.090 |
Why?
|
| Chelating Agents | 1 | 2011 | 52 | 0.090 |
Why?
|
| Macrophages | 1 | 2015 | 529 | 0.080 |
Why?
|
| Diethylstilbestrol | 2 | 2006 | 11 | 0.080 |
Why?
|
| 1-Methyl-4-phenylpyridinium | 1 | 2010 | 28 | 0.080 |
Why?
|
| Middle Aged | 1 | 2025 | 12222 | 0.080 |
Why?
|
| Herbicides | 1 | 2010 | 43 | 0.080 |
Why?
|
| Artemia | 1 | 2009 | 13 | 0.080 |
Why?
|
| Pyrrolidines | 1 | 2009 | 31 | 0.080 |
Why?
|
| Stilbenes | 1 | 2009 | 44 | 0.070 |
Why?
|
| Piperidines | 1 | 2009 | 83 | 0.070 |
Why?
|
| Environmental Pollutants | 1 | 2011 | 201 | 0.070 |
Why?
|
| Adult | 1 | 2025 | 13872 | 0.070 |
Why?
|
| Glucose | 1 | 2010 | 244 | 0.070 |
Why?
|
| Lipid Peroxidation | 3 | 2019 | 140 | 0.070 |
Why?
|
| 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 1 | 2007 | 7 | 0.070 |
Why?
|
| DNA Breaks | 1 | 2007 | 6 | 0.070 |
Why?
|
| Adenocarcinoma | 1 | 2009 | 291 | 0.060 |
Why?
|
| Cocaine | 1 | 2009 | 251 | 0.060 |
Why?
|
| Mitochondria | 1 | 2010 | 523 | 0.060 |
Why?
|
| Carcinoma | 1 | 2007 | 108 | 0.060 |
Why?
|
| Gliosis | 1 | 2004 | 25 | 0.060 |
Why?
|
| Ibuprofen | 1 | 2004 | 34 | 0.060 |
Why?
|
| Apigenin | 1 | 2004 | 14 | 0.060 |
Why?
|
| Receptors, Chemokine | 1 | 2005 | 72 | 0.050 |
Why?
|
| Glutathione | 2 | 2019 | 171 | 0.050 |
Why?
|
| Chemokines, CC | 1 | 2005 | 55 | 0.050 |
Why?
|
| Nerve Degeneration | 1 | 2004 | 111 | 0.050 |
Why?
|
| Methionine | 1 | 2002 | 27 | 0.050 |
Why?
|
| S-Adenosylmethionine | 1 | 2002 | 41 | 0.050 |
Why?
|
| Parkinsonian Disorders | 1 | 2002 | 42 | 0.050 |
Why?
|
| Lung | 1 | 2005 | 492 | 0.040 |
Why?
|
| Inflammation | 1 | 2025 | 758 | 0.040 |
Why?
|
| Cell Differentiation | 1 | 2002 | 638 | 0.040 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2018 | 110 | 0.030 |
Why?
|
| G2 Phase | 2 | 2009 | 28 | 0.030 |
Why?
|
| Prostatic Neoplasms | 1 | 2007 | 1092 | 0.030 |
Why?
|
| Rats, Inbred ACI | 2 | 2006 | 10 | 0.030 |
Why?
|
| Gene Expression Regulation | 2 | 2015 | 1070 | 0.030 |
Why?
|
| Nitrites | 1 | 2015 | 55 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 2015 | 95 | 0.030 |
Why?
|
| Neurons | 1 | 2002 | 1263 | 0.030 |
Why?
|
| Lysine | 1 | 2015 | 119 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2015 | 128 | 0.030 |
Why?
|
| Time Factors | 1 | 2019 | 1857 | 0.030 |
Why?
|
| Brain | 1 | 2002 | 1472 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2015 | 239 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2015 | 458 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 1124 | 0.020 |
Why?
|
| S Phase | 1 | 2011 | 36 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2015 | 1271 | 0.020 |
Why?
|
| Cell Respiration | 1 | 2010 | 35 | 0.020 |
Why?
|
| Vacuoles | 1 | 2009 | 22 | 0.020 |
Why?
|
| Astrocytoma | 1 | 2009 | 17 | 0.020 |
Why?
|
| Mice | 2 | 2015 | 6644 | 0.020 |
Why?
|
| Biological Assay | 1 | 2009 | 63 | 0.020 |
Why?
|
| Larva | 1 | 2009 | 133 | 0.020 |
Why?
|
| Cell Division | 1 | 2009 | 311 | 0.020 |
Why?
|
| Neuroglia | 1 | 2009 | 133 | 0.020 |
Why?
|
| Peroxides | 1 | 2007 | 19 | 0.020 |
Why?
|
| Toxicity Tests | 1 | 2007 | 44 | 0.020 |
Why?
|
| DNA Polymerase III | 1 | 2006 | 9 | 0.020 |
Why?
|
| Estrogens, Non-Steroidal | 1 | 2006 | 20 | 0.020 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2006 | 47 | 0.020 |
Why?
|
| DNA Adducts | 1 | 2006 | 37 | 0.020 |
Why?
|
| Glutathione Transferase | 1 | 2006 | 90 | 0.020 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 2006 | 51 | 0.020 |
Why?
|
| Liver | 1 | 2009 | 511 | 0.020 |
Why?
|
| Superoxide Dismutase | 1 | 2006 | 158 | 0.010 |
Why?
|
| Cell Death | 1 | 2007 | 278 | 0.010 |
Why?
|
| Chemotactic Factors, Eosinophil | 1 | 2005 | 1 | 0.010 |
Why?
|
| Chemokine CCL24 | 1 | 2005 | 2 | 0.010 |
Why?
|
| Receptors, CCR3 | 1 | 2005 | 10 | 0.010 |
Why?
|
| Estrogens | 1 | 2006 | 203 | 0.010 |
Why?
|
| Eosinophils | 1 | 2005 | 24 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 2005 | 39 | 0.010 |
Why?
|
| Annexin A5 | 1 | 2004 | 27 | 0.010 |
Why?
|
| Propidium | 1 | 2004 | 20 | 0.010 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2004 | 25 | 0.010 |
Why?
|
| Interleukin-4 | 1 | 2005 | 75 | 0.010 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2004 | 138 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2006 | 241 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2006 | 333 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2006 | 220 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2008 | 1621 | 0.010 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2004 | 146 | 0.010 |
Why?
|
| S-Adenosylhomocysteine | 1 | 2002 | 11 | 0.010 |
Why?
|
| Intracellular Fluid | 1 | 2002 | 26 | 0.010 |
Why?
|
| Culture Media, Conditioned | 1 | 2002 | 49 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2005 | 934 | 0.010 |
Why?
|
| PC12 Cells | 1 | 2002 | 93 | 0.010 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2002 | 76 | 0.010 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2002 | 64 | 0.010 |
Why?
|
| DNA Fragmentation | 1 | 2002 | 98 | 0.010 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2002 | 79 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2004 | 536 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2002 | 152 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2002 | 257 | 0.010 |
Why?
|
| Proteins | 1 | 2002 | 382 | 0.010 |
Why?
|
| Male | 1 | 2007 | 23409 | 0.000 |
Why?
|